PMID- 10081934 OWN - NLM STAT- MEDLINE DCOM- 19990506 LR - 20190701 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 261 IP - 1-2 DP - 1999 Feb 12 TI - A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. PG - 89-92 AB - The WAG/RIJ rats exhibit spontaneously occurring spike-wave discharges (SWD) accompanied by behavioural phenomena, with characteristics similar to the human absence type epilepsy. To study the mechanisms involved in this type of epileptiform activity we investigated the effects of the serotonin-1A (5-HT1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and the N-methyl-D-aspartate (NMDA) receptor antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d]cyclohepten-5,10-imine maleate (MK-801). Intracerebroventricular (i.c.v.) injection of 8-OH-DPAT caused marked, dose dependent increase, MK-801 a decrease in the cumulative duration and number of spike-wave discharges. Pretreatment with MK-801 (10 microg/rat i.c.v.) abolished the increase caused by 8-OH-DPAT (20 microg/rat i.c.v.), but the decrease in SWD to MK-801 was counterbalanced by 8-OH-DPAT. These data provide evidence for an interaction of glutamatergic and serotonergic mechanisms in the triggering and maintenance of epileptic activity in this genetic model of absence epilepsy. FAU - Filakovszky, J AU - Filakovszky J AD - Laboratory of Neurochemistry and Experimental Medicine, National Institute of Psychiatry and Neurology, Budapest, Hungary. FAU - Gerber, K AU - Gerber K FAU - Bagdy, G AU - Bagdy G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (Receptors, Serotonin) RN - 0 (Receptors, Serotonin, 5-HT1) RN - 0 (Serotonin Receptor Agonists) RN - 6LR8C1B66Q (Dizocilpine Maleate) RN - 78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin) SB - IM MH - 8-Hydroxy-2-(di-n-propylamino)tetralin/*pharmacology MH - Action Potentials/drug effects MH - Animals MH - Brain Chemistry/physiology MH - Disease Models, Animal MH - Dizocilpine Maleate/*pharmacology MH - Epilepsy, Absence/drug therapy/genetics/*physiopathology MH - Excitatory Amino Acid Antagonists/*pharmacology MH - Injections, Intraventricular MH - Male MH - Rats MH - Rats, Inbred Strains MH - Receptors, N-Methyl-D-Aspartate/*physiology MH - Receptors, Serotonin/*physiology MH - Receptors, Serotonin, 5-HT1 MH - Serotonin Receptor Agonists/*pharmacology EDAT- 1999/03/19 00:00 MHDA- 1999/03/19 00:01 CRDT- 1999/03/19 00:00 PHST- 1999/03/19 00:00 [pubmed] PHST- 1999/03/19 00:01 [medline] PHST- 1999/03/19 00:00 [entrez] AID - S0304-3940(99)00015-4 [pii] AID - 10.1016/s0304-3940(99)00015-4 [doi] PST - ppublish SO - Neurosci Lett. 1999 Feb 12;261(1-2):89-92. doi: 10.1016/s0304-3940(99)00015-4.